Clinical Trials for Prevail Therapeutics

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Prevail Therapeutics

Clinical Trials (5)

NCT06565195
A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
PHASE1Recruiting
108 participants
Started: Aug 27, 2024 · Completed: May 5, 2029
1 condition1 sponsor2 locations
NCT05487599
A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)
PHASE1/PHASE2Recruiting
15 participants
Started: Dec 20, 2022 · Completed: Oct 2, 2030
2 conditions2 sponsors8 locations
NCT04411654
Phase 1/2 Clinical Trial of PR001 in Infants With Type 2 Gaucher Disease (PROVIDE)
PHASE1/PHASE2Active, not recruiting
7 participants
Started: Jun 29, 2021 · Completed: May 31, 2028
1 condition2 sponsors5 locations
NCT04408625
Phase 1/2 Clinical Trial of LY3884963 in Patients With Frontotemporal Dementia With Progranulin Mutations (FTD-GRN)
PHASE1/PHASE2Recruiting
30 participants
Started: Nov 9, 2020 · Completed: Apr 30, 2030
1 condition2 sponsors11 locations
NCT04127578
Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL)
PHASE1/PHASE2Recruiting
20 participants
Started: Jan 3, 2020 · Completed: Dec 31, 2030
1 condition2 sponsors14 locations